Classification and treatment of the juvenile idiopathic inflammatory myopathies

Rheumatic Disease Clinics of North America

Volumn 23, Issue 3, 1997, Pages 619-655

  Rider, L G ^a   Miller, F W ^a  

^a Center for Biologics Evaluation/Res   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; METHOTREXATE;

AGED; CALCINOSIS; CHILD; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE CLASSIFICATION; FEVER; HEADACHE; HUMAN; HYPOTENSION; MYOPATHY; NAUSEA; OSTEOPOROSIS; PATHOGENESIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW;

EID: 0030870897     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70350-1     Document Type: Article

References (330)

1. M. Abinun E. Estlin D. Gardner-Medwin Failure of first-line therapy with intravenous immunoglobulin in a child with scleromyositis Br J Rheumatol 35 1996 1029 1030
2. C. Adams C.S. August H. Maguire Neuromuscular complications of bone marrow transplantation Pediatr Neurol 12 1995 58 61
3. E.M. Adams P.H. Plotz The treatment of myositis: How to approach resistant disease Rheum Dis Clin North Am 21 1995 179 202
4. B.L. Agrawal P.C. Giesen Eosinophilic myositis: An unusual cause of pseudotumor and eosinophilia JAMA 246 1981 70 71
5. M. Al-Janadi C.D. Smith J. Karsh Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis J Rheumatol 16 1989 1592 1596
6. J.N. Alpert A.E. Groff F.O. Bastian Acute polymyositis caused by sarcoidosis: Report of a case and review of the literature Mt Sinai J Med 5 1979 486 488
7. American College of Rheumatology Taskforce on Osteoporosis Guidelines Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis Arthritis Rheum 39 1996 1791 1801
8. B.A. Anderson P.V. Young W.F. Kean Polymyositis in chronic graft vs host disease: A case report Arch Neurol 39 1982 188 190
9. S. Ando S. Kobayashi K. Yamanaka [Successful combination therapy of cyclosporine and steroids in two cases with interstitial pneumonitis associated with polymyositis] Ryumachi 35 1995 95 99
10. B.M. Ansell Juvenile dermatomyositis Rheum Dis Clin North Am 17 1991 931 942
11. K. Arahata A.G. Engel Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells Ann Neurol 16 1984 193 208
12. K. Arahata A.G. Engel Monoclonal antibody analysis of mononuclear cells in myopathies. IV: Cell-mediated cytotoxicity and muscle fiber necrosis Ann Neurol 23 1988 168 173
13. S. Arase S. Kato H. Nakanishi Eosinophilic polymyositis induced by tranilast J Dermatol 17 1990 182 186
14. M.A. Bach D.M. Blum S.R. Rose Myalgia and elevated creatine kinase activity associated with subcutaneous injections of diluent J Pediatr 121 1992 650 651
15. B.Q. Banker M. Victor Dermatomyositis (systemic angiopathy) of childhood Medicine 45 1966 261 289
16. K.S. Barron M.R. Sher E.D. Silverman Intravenous immunoglobulin therapy: Magic or black magic J Rheumatol 33 suppl 1992 94 97
17. M. Basta M.C. Dalakas High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments J Clin Invest 94 1994 1729 1735
18. J. Benbassat D. Geffel A. Zlotnick Epidemiology of polymyositis-dermatomyositis in Israel, 1960–1976 Isr J Med Sci 16 1980 197 200
19. M.D. Benson M.A. Aldo Azathioprine therapy in polymyositis Arch Intern Med 132 1973 447 451
20. N. Birdi R.M. Laxer P. Thorner Localized scleroderma progressing to systemic disease Arthritis Rheum 36 1993 410 414
21. S. Bitnum C.W. Daeschner L.B. Travis Dermatomyositis J Pediatr 64 1964 101 131
22. B. Bittar C.D. Rose Early development of Hodgkin's lymphoma in association with the use of methotrexate for the treatment of dermatomyositis Ann Rheum Dis 54 1995 607 608
23. M. Blaszczyk S. Jablonska W. Szymanska-Jagiello Childhood scleromyositis: An overlap syndrome associated with polymyositis-Scl antibody Pediatr Dermatol 8 1991 1 8
24. B.J. Bloom L.B. Tucker M. Klein-Gitelman Worsening of the rash of juvenile dermatomyositis with hydroxychloroquine therapy J Rheumatol 21 1994 2171 2172
25. C. Bodemer D. Teillac Le Bourgeois M. Efficacy of intravenous immunoglobulins in sclerodermatomyositis Br J Dermatol 123 1990 545 546
26. A. Bohan J.B. Peter R.L. Bowman Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis Medicine 56 1977 255 286
27. S. Bombardieri G.R. Hughes R. Neri Cyclophosphamide in severe polymyositis Lancet 1 1989 1138 1139
28. K.E. Bove S.T. Iannaccone W. Ball Infantile myositis with leukoencephalopathy Pediatr Pathol 12 1992 289 298
29. N.E. Bowles V. Dubowitz C.A. Sewry Dermatomyositis, polymyositis, and Coxsackie-B-virus infection Lancet 1 1987 1004 1007
30. S.L. Bowyer C.E. Blane D.B. Sullivan Childhood dermatomyositis: Factors predicting functional outcome and development of dystrophic calcification J Pediatr 103 1983 882 888
31. I.M. Braverman Connective tissue (rheumatic) diseases Braverman I.M. Skin Signs of Systemic Disease, vol 2 1981 WB Saunders Philadelphia 255 377
32. D.A. Breems de Haas P.W. F. Visscher [Intravenously administered immunoglobulin first-choice remedy in autoimmune diseases?] Ned Tijdschr Geneeskd 137 1993 2336
33. J.S. Bresee E.E. Mast P.J. Coleman Hepatitis C virus infection associated with administration of intravenous immune globulin: A cohort study JAMA 276 1996 1563 1567
34. Brewer E.J. Jr E.H. Giannini R.D. Rossen Plasma exchange therapy of a childhood onset dermatomyositis patient Arthritis Rheum 23 1980 509 513
35. C.L. Bullen B.R. Younge Chronic orbital myositis Arch Ophthalmol 100 1982 1749 1751
36. T.W. Bunch Prednisone and azathioprine for polymyositis: Long-term follow-up Arthritis Rheum 24 1981 45 48
37. T.W. Bunch J.W. Worthington J.J. Combs Azathioprine with prednisone for polymyositis: A controlled, clinical trial Ann Intern Med 92 1980 365 369
38. G. Cambridge E. Ovadia D.A. Isenberg Juvenile dermatomyositis: Serial studies of circulating autoantibodies to a 56kD nuclear protein Clin Exp Rheumatol 12 1994 451 457
39. J.W. Carlisle R.A. Good Dermatomyositis in childhood Lancet 79 1959 266 273
40. J. Casademont N. Roger E. Pedrol Streptococcal myositis as a complication of juvenile dermatomyositis Neuromuscul Disord 1 1991 375 377
41. W.K. Cheong G.R. Hughes P.G. Norris Cutaneous photosensitivity in dermatomyositis Br J Dermatol 131 1994 205 208
42. P. Cherin J.C. Piette B. Wechsler Intravenous gamma globulin as first-line therapy in polymyositis and dermatomyositis: An open study in 11 adult patients [see comments] J Rheumatol 21 1994 1092 1097
43. J.F. Chmiel H.U. Wessel I.N. Targoff Pulmonary fibrosis and myositis in a child with anti–Jo-1 antibody J Rheumatol 22 1995 762 765
44. W.H. Chow G. Gridley L. Mellemkjaer Cancer risk following polymyositis and dermatomyositis: A nationwide cohort study in Denmark Cancer Causes Control 6 1995 9 13
45. M.L. Christensen L.M. Pachman R. Schneiderman Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis Arthritis Rheum 29 1986 1365 1370
46. H.T. Chung J.L. Huang H.S. Wang Dermatomyositis and polymyositis in childhood Acta Paediatr Sin 35 1994 407 414
47. A.E. Clarke D.A. Bloch Medsger T.A. Jr A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis Arthritis Rheum 38 1995 1218 1224
48. E. Colding-Jorgensen H. Laursen M. Lauritzen Focal myositis of the thigh: Report of two cases Acta Neurol Scand 88 1993 289 292
49. E. Collet S. Dalac B. Maerens Juvenile dermatomyositis: Treatment with intravenous gammaglobulin Br J Dermatol 130 1994 231 234
50. C.D. Cook F.S. Rosen B.Q. Banker Dermatomyositis and focal scleroderma Pediatr Clin North Am 10 1963 979 1016
51. C. Cooper G. Fairris D.W. Cotton Dermatomyositis associated with idiopathic thrombocytopenia Dermatologica 172 1986 173 176
52. A. Cosnes F. Amaudric R. Gherardi Dermatomyositis without muscle weakness: Long-term follow-up of 12 patients without systemic corticosteroids Arch Dermatol 131 1995 1381 1385
53. J.A. Cotterill H. Shapiro Dermatomyositis after immunisation Lancet 2 1978 1158 1159
54. A. Coutellier S. Pelletier J.J. Hauw [Inflammatory myopathy during treatment with ranitidine] Ann Med Interne (Paris) 143 1992 220 222
55. J. Craft T. Mimori T.L. Olsen The U2 small nuclear ribonucleoprotein particle as an autoantigen: Analysis with sera from patients with overlap syndromes J Clin Invest 81 1988 1716 1724
56. R.L. Cram R. Barmada W.G. Geho Diphosphonate treatment of calcinosis universalis N Engl J Med 285 1971 1012 1013
57. J.M. Crennan Van Scoy R.E. C.H. McKenna Echovirus polymyositis in patients with hypogammaglobulinemia: Failure of high–dose intravenous gammaglobulin therapy and review of the literature Am J Med 81 1986 35 42
58. M. Crisetti L. Dell'Olio P. Crociani [Granulomatous idiopathic myositis at pediatric onset: Description of a case and a review of literature] Minerva Pediatr 48 1996 271 273
59. M.E. Cronin F.W. Miller J.E. Hicks The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy J Rheumatol 16 1989 1225 1228
60. W.E. Crowe K.E. Bove J.E. Levinson Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis Arthritis Rheum 25 1982 126 139
61. A.N. Crowson C.M. Magro The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis Hum Pathol 27 1996 15 19
62. J. Cukier R.A. Beauchamp J.S. Spindler Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome Ann Intern Med 118 1993 920 928
63. J.J. Curran T.W. Jamieson Dermatomyositis-like syndrome associated with phenylbutazone therapy J Rheumatol 14 1987 397 398
64. M.C. Dalakas High-dose intravenous immunoglobulin and serum viscosity: Risk of precipitating thromboembolic events Neurology 44 1994 223 226
65. M.C. Dalakas I. Illa J.M. Dambrosia A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis N Engl J Med 329 1993 1993 2000
66. P. Dantzig Juvenile dermatomyositis treated with cyclosporine J Am Acad Dermatol 22 1990 310 311
67. P.C. Dau J.L. Bennington Plasmapheresis in childhood dermatomyositis J Pediatr 98 1981 237 240
68. De Vita S. V. Fossaluzza Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: Clinical experience and a review of the literature Acta Neurol Belg 92 1992 215 227
69. De Wilde A. F.X. DiSpaltro A. Geller Extracorporeal photochemotherapy as adjunctive treatment in juvenile dermatomyositis: A case report Arch Dermatol 128 1992 1656 1657
70. C.E. Dent T.C.B. Stamp Treatment of calcinosis circumscripta with probenecid BMJ 1 1972 216 128
71. A.L. Dolan D. Kassimos T. Gibson Diltiazem induces remission of calcinosis in scleroderma Br J Rheumatol 34 1995 576 578
72. L.A. Drake S.M. Dinehart E.R. Farmer Guidelines of care for dermatomyositis: American Academy of Dermatology J Am Acad Dermatol 34 1996 824 829
73. B. Drouet Le Loet X. O. Vittecoq A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis Rev Rhum Engl Ed 63 1996 321 330
74. V. Dubowitz Treatment of dermatomyositis in childhood Arch Dis Child 51 1976 494 500
75. S.P. Dunn G.F. Cooney A. Kulinsky Absorption characteristics of a microemulsion formulation of cyclosporine in de novo pediatric liver transplant recipients Transplantation 60 1995 1438 1442
76. W. Ehrengut Dermatomyositis and vaccination Lancet 1 1978 1040 1041
77. D.M. Eisenstein A.S. Paller L.M. Pachman Juvenile dermatomyositis presenting with rash alone; late onset of myositis Arthritis Rheum 39 suppl 1996 192
78. J.R. Elkington A.D. Hunt L. Godfrey Effects of pituitary adrenocorticotropic hormone (ACTH) therapy JAMA 141 1949 1273 1279
79. G.L. Ellis R.B. Brannon Focal myositis of the perioral musculature Oral Surg 48 1979 337 341
80. A.M. Emslie-Smith A.G. Engel Microvascular changes in early and advanced dermatomyositis: A quantitative study Ann Neurol 27 1990 343 356
81. M.H. Ens-Dokkum A.C.B. Peters Infantile myositis Tijdschr Kindergeneeskd 53 1985 158 160
82. F.M. Enzinger F. Dulcey Proliferative myositis. Report of thirty-three cases Cancer 20 1967 2213 2223
83. A. Escalante L. Miller T.D. Beardmore Resistive exercise in the rehabilitation of polymyositis/dermatomyositis J Rheumatol 20 1993 1340 1344
84. L.R. Espinoza J.L. Aguilar C.G. Espinoza Characteristics and pathogenesis of myositis in human immunodeficiency virus infection: Distinction from azidothymidine-induced myopathy Rheum Dis Clin North Am 17 1991 117 129
85. R.E. Ettenger H.T. Smith B. Kaiser Use of Neoral in pediatric renal transplantation Transplant Proc 28 1996 2257 2258
86. R.L. Euwer R.D. Sontheimer Dermatologic aspects of myositis Curr Opin Rheumatol 6 1994 583 589
87. R.G. Fafalak M.G. Peterson L.J. Kagen Strength in polymyositis and dermatomyositis: Best outcome in patients treated early J Rheumatol 21 1994 643 648
88. F. Falcini G. Taccetti S. Trapani Acute lymphocytic leukemia with dermatomyositis-like onset in childhood J Rheumatol 20 1993 1260 1262
89. F. Falcini S. Trapani M. Ermini Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling Calcif Tissue Int 58 1996 166 169
90. D. Faulds K.L. Goa P. Benfield Cyclosporin: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in immunoregulatory disorders Drugs 45 1993 953 1040
91. B.M. Feldman M. Reichlin R.M. Laxer Clinical significance of specific autoantibodies in juvenile dermatomyositis J Rheumatol 23 1996 1794 1797
92. D.R. Finger P.H. Plotz G. Heywood Myositis following treatment with high-dose interleukin-2 for malignancy J Rheumatol 22 1995 2188
93. T.H. Finkel T.J. Torok P.J. Ferguson Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent? Lancet 343 1994 1255 1258
94. T.J. Fischer G.S. Rachelefsky R.B. Klein Childhood dermatomyositis and polymyositis: Treatment with methotrexate and prednisone Am J Dis Child 133 1979 386 389
95. J.G. Fort R. Griffin A. Tahmoush Muscle involvement in polyarteritis nodosa: Report of a patient presenting clinically as polymyositis and review of the literature J Rheumatol 21 1994 945 948
96. D. Fuchs L. Fruchter B. Fishel Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis Clin Rheumatol 5 1986 527 530
97. M. Galeazzi A.M. Bellucci C.R. Girardelli Efficacy of intravenous immunoglobulin therapy in a case of juvenile dermatomyositis Clin Rheumatol 15 1996 215 216
98. C. Gama K. Breeden R. Miller Myositis in Kawasaki disease Pediatr Neurol 6 1990 135 136
99. J. Garcia-Consuegra C. Morales J. Gonzalez Relapsing focal myositis: A case report Clin Exp Rheumatol 13 1995 395 397
100. V. Garcia-Patos R. Bartralot V. Fonollosa Childhood sclerodermatomyositis: Report of a case with the anti-polymyositis/Scl antibody and mechanic's hands Br J Dermatol 135 1996 613 616
101. F.N. Ghadially M.J. Thomas M. Jabi Intracisternal collagen fibrils in proliferative fasciitis and myositis of childhood Ultrastruct Pathol 17 1993 161 168
102. E. Giardin J.M. Dayer L. Paunier Cyclosporine for juvenile dermatomyositis J Pediatr 112 1988 165 166
103. A. Goel N. Fertig C.V. Oddis Serum autoantibodies in idiopathic inflammatory myopathy of childhood Arthritis Rheum 39 suppl 1996 191
104. D.L. Goldenberg R.A. Stor Azathioprine hypersensitivity mimicking an acute exacerbation of dermatomyositis J Rheumatol 2 1975 346 349
105. J.W. Gould M.G. Mercurio C.A. Elmets Cutaneous photosensitizing diseases induced by exogenous agents J Am Acad Dermatol 33 1995 551 573
106. R.C. Griggs V. Askanas S. DiMauro Inclusion body myositis and myopathies Ann Neurol 38 1995 705 713
107. J.J. Grob A.M. Collet J.J. Bonerandi Dermatomyositis-like syndrome induced by nonsteroidal anti-inflammatory agents Dermatologica 178 1989 58 59
108. W.B. Gruhn J.A. Diaz-Buxo Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis J Rheumatol 14 1987 1045 1047
109. D.C. Haas Treatment of polymyositis with immunosuppressive drugs Neurology 23 1973 55 62
110. H.J. Haga D. D'Cruz R. Asherson Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis Ann Rheum Dis 51 1992 885 888
111. E. Hagiwara E. Adams P.H. Plotz Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis Clin Exp Rheumatol 1411 1996 485 491
112. J. Hamalova O. Rozhold A. Petrikova A contribution to the problem of atypical polymyositis in children Acta Univ Palacki Olomuc Fac Med 131 1991 251 256
113. M. Hamza Pharyngeal stenosis in Behçet's disease Clin Exp Rheumatol 6 1988 139 140
114. A.S. Hanissian J. Martinez J.T. Jabbour Vasculitis and myositis secondary to rubella vaccination Arch Neurol 28 1973 202 204
115. A.S. Hanissian A.T. Masi S.E. Pitner Polymyositis and dermatomyositis in children: An epidemiologic and clinical comparative analysis J Rheumatol 9 1982 390 394
116. G.J. Hankey P.L. Silbert R.H. Edis Orbital myositis: A study of six cases Aust N Z J Med 17 1987 585 591
117. V. Hansen H. Kornreich Systemic rheumatic disorders (“collagen disease”) in childhood: Lupus erythematosus, anaphylactoid purpura, dermatomyositis, and scleroderma, Part 2 Bull Rheum Dis 17 1967 441 446
118. J. Heckmatt N. Hasson C. Saunders Cyclosporin in juvenile dermatomyositis Lancet 1 1989 1063 1066
119. Heffner R.R. Jr V.W. Armbrustmacher K.M. Earle Focal myositis Cancer 40 1977 301 306
120. K.G. Henricksson B. Lindvall Polymyositis and dermatomyositis 1990—diagnosis, treatment and prognosis Prog Neurobiol 35 1990 181 193
121. J.E. Hicks Exercise in patients with inflammatory arthritis and connective tissue disease Rheum Dis Clin North Am 16 1990 845 870
122. R.H. Hill W.S. Wood Juvenile dermatomyositis Can Med Assoc J 103 1970 1152 1156
123. D.A. Hilton A. Fletcher J.H. Pringle Absence of coxsackieviruses in idiopathic inflammatory muscle disease by in situ hybridization Neuropathol Appl Neurobiol 20 1994 238 242
124. M. Hirakata A. Suwa M. Kron Anti-KS: Novel autoantibodies to asparaginyl-transfer RNA synthetase Arthritis Rheum 39 suppl 1996 39
125. F. Hirano H. Tanaka Y. Nomura Successful treatment of refractory polymyositis with pulse intravenous cyclophosphamide and low-dose weekly oral methotrexate therapy Intern Med 32 1993 749 752
126. R.W. Hoffman J.T. Cassidy Y. Takeda U1-70-kd autoantibody-positive mixed connective tissue disease in children: A longitudinal, clinical, and serologic analysis Arthritis Rheum 36 1993 1599 1602
127. H.B. Hoh R.D. Laitt C. Wakeley The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease Eye 8 1994 506 510
128. H.W. Horowitz K. Sanghera N. Goldberg Dermatomyositis associated with Lyme disease: Case report and review of Lyme myositis Clin Infect Dis 18 1994 166 171
129. K.R. Houpt R.D. Sontheimer Autoimmune connective tissue disease and connective tissue disease-like illnesses after silicone gel augmentation mammoplasty J Am Acad Dermatol 31 1994 626 642
130. P.F. Hoyer Complications of cyclosporin therapy Contrib Nephrol 114 1995 111 123
131. I. Illa A. Nath M. Dalakas Immunocytochemical and virological characertistics of HIV-associated inflammatory myopathies: Similarities with seronegative polymyositis Ann Neurol 29 1991 474 481
132. G. Isaacson K.H. Chan Heffner R.R. Jr Focal myositis: A new cause for the pediatric neck mass Arch Otolaryngol Head Neck Surg 117 1991 103 105
133. S. Jablonska T.P. Chorzelski M. Blaszczyk Scleroderma/polymyositis overlap syndromes and their immunologic markers Clin Dermatol 10 1992 457 472
134. J.C. Jacobs Methotrexate and azathioprine treatment of childhood dermatomyositis Pediatrics 59 1977 212 218
135. J.C. Jacobs Dermatomyositis Jacobs J.C. Pediatric rheumatology for the practitioner, vol 2 1993 Springer-Verlag New York 527 555
136. F. Jerusalem G. Baumgartner R. Wyler Virus-ahnliche Einschlusse bei chronischen neuromuskularen Prozessen: Elektronenmikroskopische biopsiefunde von 2 fallen Arch Psychiat Nervenkr 215 1972 148 166
137. F. Jerusalem P. Imbach [Granulomatous myositis and muscle sarcoidosis: Clinical picture and biopsy histological diagnosis] Dtsch Med Wochenschr 95 1970 2184 2190
138. M.M. Joffe L.A. Love R.L. Leff Drug therapy of the idiopathic inflammatory myopathies: Predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy Am J Med 94 1993 379 387
139. A. Kadoya J. Okada Y. Iikuni Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus J Rheumatol 23 1996 1186 1188
140. M. Kalmanti A. Athanasiou Neuroblastoma occurring in a child with dermatomyositis Am J Pediatr Hematol Oncol 7 1985 387 388
141. O.W. Kamel van de Rijn M. D.P. LeBrun Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: Frequency of Epstein-Barr virus and other features associated with immunosuppression Hum Pathol 25 1994 638 643
142. O.W. Kamel van de Rijn M. L.M. Weiss Brief report: Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis N Engl J Med 328 1993 1317 1321
143. E. Kass S. Straume E. Munthe Dermatomyositis after BCG vaccination Lancet 1 1978 772
144. L.D. Kaufman G.M. Kephart R.J. Seidman The spectrum of eosinophilic myositis: Clinical and immunopathogenic studies of three patients, and review of the literature Arthritis Rheum 36 1993 1014 1024
145. S. Kaveri T. Vassilev V. Hurez Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use J Clin Invest 97 1996 865 869
146. A. Kedar A.B. Khan Mattern J.Q.A. III Autoimmune disorders complicating adolescent Hodgkin's disease Cancer 44 1979 112 116
147. F.H. Khattak I.M. Morris W.A. Branford Simvastatin-associated dermatomyositis Br J Rheumatol 33 1994 199
148. H.A. Kim Y.W. Song Polymyositis developing after prolonged injections of pentazocine J Rheumatol 23 1996 1644 1646
149. J.T. Kissel J.R. Mendell K.W. Rammohan Microvasculature deposition of complement membrane attack complex in dermatomyositis N Engl J Med 314 1986 329 334
150. M.S. Klein-Gitelman I.S. Szer Disseminated Nocardia brasiliensis infection: An unusual complication of immunosuppressive treatment for childhood dermatomyositis J Rheumatol 18 1991 1243 1246
151. M. Koch J.A. Brody G.J. Nemo Antibody levels to parainfluenza, rubella, measles, and influenza A virus in children with polymyositis Arthritis Rheum 18 1975 353 355
152. M.J. Koch J.A. Brody M.M. Gillespie Childhood polymyositis: A case-control study Am J Epidemiol 104 1976 627 631
153. A. Konohana J. Kawashima Successful treatment of dermatomyositis with dapsone Clin Exp Dermatol 19 1994 367
154. J. Korda G. Genti G. Kali Successful treatment of respiratory failure associated with dermatomyositis J Rheumatol 14 1987 1075 1076
155. A. Koutras Myositis with Kawasaki's disease Am J Dis Child 136 1982 78 79
156. E. Kowalska-Oledzka M. Jarzabek-Chorzelska Z. Kolacinska-Strasz [Anti–MI-2 antibody as a specific marker of dermatomyositis] Neurol Neurochir Pol 29 1995 703 711
157. B. Lang J. Dooley Failure of pulse intravenous methylprednisolone treatment in juvenile dermatomyositis J Pediatr 128 1996 429 432
158. B.A. Lang R.M. Laxer G. Murphy Treatment of dermatomyositis with intravenous gammaglobulin Am J Med 91 1991 169 172
159. B.A. Lang R.M. Laxer P. Thorner Pediatric onset of Behçet's syndrome with myositis: Case report and literature review illustrating unusual features Arthritis Rheum 33 1990 418 425
160. A.J. Larner S.G. Sturman J.B. Hawkins Myopathy with ragged red fibres following renal transplantation: Possible role of cyclosporin-induced hypomagnesaemia Acta Neuropathol 88 1994 189 192
161. K. Lassoued P. Saiag M.C. Anglade Failure of warfarin in treatment of calcinosis universalis Am J Med 84 1988 795 796
162. R.M. Laxer L.D. Stein R.E. Petty Intravenous pulse methylprednisolone treatment of juvenile dermatomyositis Arthritis Rheum 30 1987 328 334
163. J.S. Le Quintrec Le Quintrec J.L. Drug–induced myopathies Baillieres Clin Rheumatol 5 1991 21 38
164. C. Leaute-Labreze Y. Perel A. Taieb Childhood dermatomyositis associated with hepatocarcinoma N Engl J Med 333 1995 1083
165. H.M. Lederman J.A. Winkelstein X-linked agammaglobulinemia: An analysis of 96 patients Medicine 64 1985 145 156
166. R.L. Leff F.W. Miller J. Hicks The treatment of inclusion body myositis: A retrospective review and a randomized, prospective trial of immunosuppressive therapy Medicine 72 1993 225 235
167. J.P. Leroy A.A. Drosos D.I. Yiannopoulos Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome Arthritis Rheum 33 1990 1579 1581
168. R.M. Lewkonia D. Horne M.R. Dawood Juvenile dermatomyositis in a child infected with human parvovirus B19 Clin Infect Dis 21 1995 430 432
169. L.A. Love R.L. Leff D.D. Fraser A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups Medicine 70 1991 360 374
170. L.A. Love F.W. Miller Noninfectious environmental agents associated with myopathies Curr Opin Rheumatol 5 1993 712 718
171. L.A. Love S.R. Weiner F.B. Vassey Clinical and immunogenetic features of women who develop myositis after silicone implants (MASI) Arthritis Rheum 35 suppl 1992 46
172. F.J. Maccioni H.J. Colebatch Management of fibrosing alveolitis with polymyositis dermatomyositis Aust N Z J Med 20 1990 806 810
173. A.N. Malaviya A. Many R.S. Schwartz Treatment of dermatomyositis with methotrexate Lancet 2 1968 485 488
174. P. Mancias T.P. Bohan I.J. Butler Treatment-resistant eosinophilic polymyositis in a child J Child Neurol 9 1994 446 448
175. J. Marcum HIV infection presenting as polymyositis Del Med J 67 1995 185
176. C. Marguerie C.C. Bunn J. Copier The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen polymyositis-Scl Medicine 71 1992 327 336
177. A. Martini A. Ravelli S. Albani Recurrent juvenile dermatomyositis and cutaneous necrotizing arteritis with molecular mimicry between streptococcal type 5 M protein and human skeletal myosin J Pediatr 121 1992 739 742
178. Mascaro J.M. Jr G. Hausmann C. Herrero Membrane attack complex deposits in cutaneous lesions of dermatomyositis Arch Dermatol 131 1995 1386 1392
179. F.L. Mastaglia V.J. Ojeda Inflamamtory myopathies: Part 1 Ann Neurol 17 1985 215 227
180. F.L. Mastaglia V.J. Ojeda Inflammatory myopathies: Part 2 Ann Neurol 17 1985 317 323
181. M. Matsuya T. Abe M. Tosaka The first case of polymyositis associated with interferon therapy Intern Med 33 1994 806 808
182. D.E. McFarlin R.C. Griggs Treatment of inflammatory myopathies with azathioprine Trans Am Neurol Assoc 93 1968 244 246
183. McKinney R.E. Jr S.L. Katz C.M. Wilfert Chronic enteroviral meningoencephalitis in agammaglobulinemic patients Rev Infect Dis 9 1987 334 356
184. P.J. Mease H.D. Ochs L. Corey Echovirus encephalitis/myositis in X-linked agammaglobulinemia N Engl J Med 313 1985 758
185. J.M. Meis F.M. Enzinger Proliferative fasciitis and myositis of childhood Am J Surg Pathol 16 1992 364 372
186. B.C. Mendelson R.L. Linscheid J.H. Dobyns Surgical treatment of calcinosis cutis in the upper extremity J Hand Surg [Am] 2 1977 318 324
187. A.L. Metzger A. Bohan L.S. Goldberg Polymyositis and dermatomyositis: Combined methotrexate and corticosteroid therapy Ann Intern Med 81 1974 182 189
188. A.L. Metzger F.R. Singer R. Bluestone Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma N Engl J Med 291 1974 1294 1296
189. R. Mier B. Ansell M.A. Hall Long-term follow-up of children with mixed connective tissue disease Lupus 5 1996 221 226
190. F.W. Miller Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies JAMA 270 1993 1846 1849
191. F.W. Miller Classification and prognosis of inflammatory muscle disease Rheum Dis Clin North Am 20 1994 811 826
192. F.W. Miller S.F. Leitman M.E. Cronin Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis N Engl J Med 326 1992 1380 1384
193. J.J. Miller Late progression in dermatomyositis in childhood J Pediatr 83 1973 543 548
194. L.C. Miller A.F. Michael Y. Kim Childhood dermatomyositis. Clinical course and long-term follow-up Clin Pediatr 26 1987 561 566
195. L.C. Miller B.A. Sisson L.B. Tucker Methotrexate treatment of recalcitrant childhood dermatomyositis Arthritis Rheum 35 1992 1143 1149
196. M.L. Miller L. Levinson L.M. Pachman Abnormal muscle MRI in a patient with systemic juvenile arthritis Pediatr Radiol 25 suppl 1 1995 107 108
197. F. Millot F. Mechinaud J.L. Harousseau Acute lymphoblastic leukemia associated with dermatomyositis in a child Pediatr Dermatol 10 1993 199 200
198. Y. Misaki G.J.M. Pruijn van der Kemp W.C.M. The 56K autoantigen is identical to human annexin XI J Biol Chem 269 1994 4240 4246
199. Y. Misaki van Venrooij W.J. G.J. Pruijn Prevalence and characteristics of anti-56K/annexin XI autoantibodies in systemic autoimmune diseases J Rheumatol 22 1995 97 102
200. C.M. Moorman J.S. Elston Acute orbital myositis Eye 9 1995 96 101
201. L. Mouthon S.V. Kaveri S.H. Spalter Mechanisms of action of intravenous immune globulin in immune-mediated diseases Clin Exp Immunol 104 suppl 1 1996 3 9
202. E. Murphy R. Freaney B. Bresnihan Evidence for increased bone turnover in patients with dystrophic calcification Arthritis Rheum 39 suppl 1996 97
203. T. Nagai T. Hasegawa M. Saito Infantile polymyositis: A case report Brain Dev 14 1992 167 169
204. H. Nagar Y. Bar-Ziv Focal eosinophilic myositis: Unusual cause of a tumour on the chest wall Eur J Surg 159 1993 187 188
205. T. Nakagawa T. Takaiwa Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment J Dermatol 20 1993 558 560
206. J.R. Nassim C.K. Connolly Treatment of calcinosis universalis with aluminum hydroxide Arch Dis Child 45 1970 118 121
207. M. Naughton J.D. Jessop B.D. Williams Idiopathic recurrent nonsuppurative focal myositis: A report of two cases Br J Rheum 32 1993 1101 1104
208. Y. Nevo A. Pestronk Neonatal perifascicular myopathy Pediatr Neurol 15 1996 150 152
209. E. Niakan S.E. Pitner J.N. Whitaker Immunosuppressive agents in corticosteroid-refractory childhood dermatomyositis Neurology 30 1980 286 291
210. M. Nishikai M. Miyairi S. Kosaka Dermatomyositis following infection with hepatitis C virus J Rheumatol 21 1994 1584 1585
211. T.P. O'Hanlon F.W. Miller T cell-mediated immune mechanisms in myositis Curr Opin Rheumatol 7 1995 503 509
212. C.V. Oddis P. Carroll K. Abu-Elmaod FK 506 in the treatment of polymyositis Arthritis Rheum 37 suppl 1994 286
213. C.V. Oddis Y. Okano W.A. Rudert Serum autoantibody to the nucleolar antigen polymyositis-Scl: Clinical and immunogenetic associations Arthritis Rheum 35 1992 1211 1217
214. S. Okada P.J. Rohan F.W. Miller Myopathies following ingestion of special nutritional products Arthritis Rheum 39 suppl 1996 49
215. Y. Okano V.D. Steen Medsger T.A. Jr Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis Arthritis Rheum 35 1992 95 100
216. Y. Okano I.N. Targoff C.V. Oddis Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: A rare anti-U snRNP specificity Clin Immunol Immunopathol 81 1996 41 47
217. M.G. Oliveri R. Palermo C. Mautalen Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis J Rheumatol 23 1996 2152 2155
218. N.Y. Olson C.B. Lindsley Adjunctive use of hydroxychloroquine in childhood dermatomyositis J Rheumatol 16 1989 1545 1547
219. B.E. Ostrov D.P. Goldsmith A.H. Eichenfield Hypercalcemia during the resolution of calcinosis universalis in juvenile dermatomyositis J Rheumatol 18 1991 1730 1734
220. L.M. Pachman Juvenile dermatomyositis: A clinical overview Pediatr Rev 12 1990 117 125
221. L.M. Pachman Polymyositis and dermatomyositis in children P.J. Maddison D.A. Isenberg Woo P. Oxford Textbook of Rheumatology, vol 1 1993 Oxford University Press Oxford 821 828
222. L.M. Pachman Inflammatory myopathy in children Rheum Dis Clin North Am 20 1994 919 942
223. L.M. Pachman Juvenile dermatomyositis. Pathophysiology and disease expression Pediatr Clin North Am 42 1995 1071 1098
224. L.M. Pachman A.M. Callen J. Hayford Juvenile dermatomyositis: Decreased calcinosis with intermittent high-dose intravenous methylprednisolone therapy Arthritis Rheum 37 suppl 1994 429
225. L.M. Pachman J.R. Hayford J. Sinacore New onset juvenile dermatomyositis (JDMS): A clinical description Arthritis Rheum 35 1992 88
226. L.M. Pachman D.L. Litt A.H. Rowley Lack of detection of enteroviral RNA or bacterial DNA in MR imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis Arthritis Rheum 38 1995 1513 1518
227. A.R. Page A.E. Hansen R.A. Good Occurrence of leukemia and lymphoma in patients with agammaglobulinemia Blood 21 1963 197 206
228. G.M. Palmieri J.I. Sebes J.A. Aelion Treatment of calcinosis with diltiazem Arthritis Rheum 38 1995 1646 1654
229. P. Parker N.J. Chao J. Ben-Ezra Polymyositis as a manifestation of chronic graft-versus-host disease Medicine 75 1996 279 285
230. A. Parodi A. Rebora Anti-Ku antibodies in connective tissue diseases J Am Acad Dermatol 21 1989 433 435
231. H. Patapanian S. Graham P.N. Sambrook The oncogenicity of chlorambucil in rheumatoid arthritis Br J Rheumatol 27 1988 44 47
232. M.D. Perez S.A. Abrams G. Koenning Mineral metabolism in children with dermatomyositis J Rheumatol 21 1994 2364 2369
233. J.R. Person Dermatomyositis responding to pentoxifylline Br J Dermatol 134 1996 593
234. A.M. Peters J.Z. Heckmatt N. Hasson Renal haemodynamics of cyclosporin A nephrotoxicity in children with juvenile dermatomyositis Clin Sci 81 1991 153 159
235. V. Pistoia A. Buoncompagni R. Scribanis Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study Clin Exp Rheumatol 11 1993 203 208
236. R.A. Pittsley M.A. Shearn L. Kaufman Acute hepatitis B simulating dermatomyositis JAMA 239 1978 959
237. P.N. Plowman D.E. Stableforth Dermatomyositis with fibrosing alveolitis: Response to treatment with cyclophosphamide Proc R Soc Med 70 1977 738 740
238. S.K. Poddar S. Misra N.K. Singh Acute polymyositis associated with W. bancrofti Acta Neurol Scand 89 1994 225 226
239. Z.F. Pollard Acute rectus muscle palsy in children as a result of orbital myositis J Pediatr 128 1996 230 233
240. C.E. Potain Morve chronique de forme anormale Bull Soc Hop Paris 12 1875 314
241. G. Ramirez R.A. Asherson M.A. Khamashta Adult-onset polymyositis-dermatomyositis: Description of 25 patients with emphasis on treatment Semin Arthritis Rheum 20 1990 114 120
242. D.J. Rawlings L. Richardson I.S. Szer Cyclosporine is safe and effective in refractory JRA and JDMS: Results of an open clinical trial Arthritis Rheum 35 suppl 1992 188
243. A. Reed M. Haugen L.M. Pachman Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases J Pediatr 116 1990 574 580
244. A.M. Reed D.W. Kredich L.E. Schanberg Seldom recognized cutaneous manifestations of juvenile dermatomyositis Arthritis Rheum 39 suppl 1996 190
245. A.M. Reimold M.E. Weinblatt Tachyphylaxis of intravenous immunoglobulin in refractory inflammatory myopathy J Rheumatol 21 1994 1144 1146
246. Research Group on Neuromuscular Diseases of the World Federation of Neurology Classification of the neuromuscular diseases J Neurol 19 1968 545 566
247. L.G. Rider Assessment of disease activity and its sequelae in children and adults with myositis Curr Opin Rheumatol 8 1996 495 506
248. L.G. Rider P. Lachenbruch R. Rennebohm Identifying skin lesions in dermatomyositis: Inter-rater reliability of a new cutaneous assessment tool Arthritis Rheum 38 suppl 1996 168
249. L.G. Rider F.W. Miller I.N. Targoff A broadened spectrum of juvenile myositis: Myositis-specific autoantibodies in children Arthritis Rheum 37 1994 1534 1538
250. L.G. Rider S. Okada D.D. Sherry Epidemiologic features and environmental exposures associated with illness onset in juvenile idiopathic inflammatory myopathy Arthritis Rheum 38 suppl 1995 362
251. L.G. Rider S. Okada D.D. Sherry Presentations and disease courses of juvenile idiopathic inflammatory myopathy Arthritis Rheum 38 suppl 1995 362
252. L.G. Rider I.N. Targoff R.L. Leff Association of autoantibodies to the U5-ribonucleoprotein (U5-RNP) with idiopathic inflammatory myopathy Arthritis Rheum 37 suppl 1994 242
253. L.G. Rider I.N. Targoff E.S. Taylor-Albert Anti–Jo-1 autoantibodies define a clinically homogenous subset of childhood idiopathic inflammatory myopathy Arthritis Rheum 38 suppl 1995 362
254. J.E. Riggs Schochet S.S. Jr L. Gutmann Childhood onset inclusion body myositis mimicking limb-girdle muscular dystrophy J Child Neurol 4 1989 283 285
255. S.M. Roddy S. Ashwal N. Peckham Infantile myositis: A case diagnosed in the neonatal period Pediatr Neurol 2 1986 241 244
256. C.M. Roifman Use of intravenous immune globulin in the therapy of children with rheumatological diseases J Clin Immunol 159 suppl 1995 42 51
257. A.M. Romicka [Use of intravenous megadoses of methylprednisolone for treatment of dermatomyositis in children] Pediatr Pol 70 1995 243 248
258. A.L. Rose Childhood polymyositis: A follow-up study with special reference to treatment with corticosteroids Am J Dis Child 127 1974 518 522
259. T. Rose J. Nothjunge W. Schlote Familial occurrence of dermatomyositis and progressive scleroderma after injection of a local anaesthetic for dental treatment Eur J Pediatr 143 1985 225 228
260. C. Saadeh W. Bridges F. Burwick Dermatomyositis: Remission induced with combined oral cyclosporine and high-dose intravenous immune globulin South Med J 88 1995 866 870
261. K.G. Saag R. Koehnke J.R. Caldwell Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events Am J Med 96 1994 115 123
262. J. Sanchez-Roman M.J. Castillo-Palma C. Ocana-Medina Eficacia de la cicosporina en al tratamiento de las miositis Rev Clin Esp 195 1995 449 454
263. A. Sansome V. Dubowitz Intravenous immunoglobulin in juvenile dermatomyositis: Four-year review of nine cases Arch Dis Child 72 1995 25 28
264. J. Santos Duran-Ortiz Garcia-de la Torre I. G. Orozco-Barocio Trichinosis with severe myopathic involvement mimicking polymyositis: Report of a family outbreak J Rheumatol 19 1992 310 312
265. J.W. Scharf D.V. Michalk [Plasma separation in severe juvenile dermatomyositis] Monatsschr Kinderheilkd 133 1985 49 51
266. K. Schmidt M. Westenberger-Treumann R. Stadler [High dosage intravenous gamma globulin therapy in juvenile dermatomyositis] Hautarzt 45 1994 854 857
267. H.M. Schroter H.B. Sarnat D.S. Matheson Juvenile dermatomyositis induced by toxoplasmosis J Child Neurol 2 1987 101 104
268. K.B. Seidenberg M.L. Leib Orbital myositis with Lyme disease Am J Ophthalmol 109 1990 13 16
269. E.A. Sekul E.J. Cupler M.C. Dalakas Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors Ann Intern Med 121 1994 259 262
270. G. Serratrice J.F. Pellissier A. Schiano Neuf cas de polymyosites segmentaires Sem Hop Paris 60 1984 3189 3191
271. G. Serratrice A. Schiano J.F. Pellissier Les expressions anatomocliniques des polymyosites chez l'enfant: Vingt-trois cas Ann Pediatr 36 1989 237 243
272. M.J. Shapiro H. Applebaum A.S. Besser Cervical focal myositis in a child J Pediatr Surg 21 1986 375 376
273. J.C. Shearin K. Pickrell Surgical treatment of subcutaneous calcifications of polymyositis or dermatomyositis Ann Plast Surg 5 1980 381 385
274. J.H. Sheldon F. Young S.C. Dyke Acute dermatomyositis associated with reticulo-endotheliosis Lancet 1 1939 82 84
275. W.J. Shergy D.S. Caldwell Polymyositis after propylthiouracil treatment for hyperthyroidism Ann Rheum Dis 47 1988 340 343
276. D.D. Sherry J.E. Haas J.M. Milstein Childhood polymyositis as a paraneoplastic phenomenon Pediatr Neurol 9 1993 155 156
277. M. Shevell B. Rosenblatt K. Silver Congenital inflammatory myopathy Neurol 40 1990 1111 1114
278. D.T. Shuhart D.J. Torretti J.F. Maksimak Acute myositis as an unusual presentation of Wegener's granulomatosis Arch Pediatr Adolesc Med 148 1994 875 876
279. R.M. Siatkowski H. Capo S.F. Byrne Clinical and echographic findings in idiopathic orbital myositis Am J Ophthalmol 118 1994 343 350
280. B. Singsen B. Goldreyer R. Stanton Childhood polymyositis with cardiac conduction defects Am J Dis Child 130 1976 72 74
281. B.H. Singsen B.H. Bernstein H.K. Kornreich Mixed connective tissue disease in childhood: A clinical and serologic survey J Pediatr 90 1977 893 900
282. B.H. Singsen K.D. Waters S.E. Siegel Lymphocytic leukemia, atypical dermatomyositis, and hyperlipidemia in a 4-year-old boy J Pediatr 88 1976 602 604
283. P.A. Sinoway J.P. Callen Chlorambucil: An effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis Arthritis Rheum 36 1993 319 324
284. P.A. Sinoway C.L. Davidson J.P. Callen Dermatomyositis occurring during psoralen A (PUVA) therapy J Rheumatol 21 1994 353 356
285. M.L. Slavin J.S. Glaser Idiopathic orbital myositis: Report of six cases Arch Ophthalmol 100 1982 1261 1265
286. D. Smadja R. Bellance P. Cabre Clinical characteristics of HTLV-1 associated dermato-polymyositis: Seven cases from Martinique Acta Neurol Scand 92 1995 206 212
287. S.D. Solomon K.H. Maurer Association of dermatomyositis and dysgerminoma in a 16-year-old patient Arthritis Rheum 26 1983 572 573
288. R.D. Sontheimer Photoimmunology of lupus erythematosus and dermatomyositis: A speculative review Photochem Photobiol 63 1996 583 594
289. C.H. Spencer V. Hanson B.H. Singsen Course of treated juvenile dermatomyositis J Pediatr 105 1984 399 408
290. A. Spindler A. Berman M. Braier Lithotripsy: A novel therapeutic approach for calcific tendinitis refractory to conventional therapy Arthritis Rheum 39 suppl 1996 134
291. Squires R.H. Jr R.J. Zwiener R.H. Kennedy Orbital myositis and Crohn's disease J Pediatr Gastroenterol Nutr 15 1992 448 451
292. J. Stary S. Havelka O. Hrodek Syndrome of secondary polymyositis with leukemia Acta Univers Carol Med 37 1991 16 20
293. L. Steidl R. Ditmar Soft-tissue calcification treated with local and oral magnesium therapy Magnes Res 3 1990 113 119
294. L. Steidl R. Ditmar Treatment of soft tissue calcifications with magnesium Acta Univ Palacki Olomuc Fac Med 130 1991 273 287
295. W.R. Steiner Dermatomyositis, with report of a case which presented a rare muscle anomaly but once described in man J Exp Med 6 1903 407 442
296. M.R. Stonecipher J.P. Callen J.L. Jorizzo The red face: Dermatomyositis Clin Dermatol 11 1993 261 273
297. M.R. Stonecipher J.L. Jorizzo W.L. White Cutaneous changes of dermatomyositis in patients with normal muscle enzymes: Dermatomyositis sine myositis? J Am Acad Dermatol 28 1993 951 956
298. H. Sugie Y. Sugie M. Ichimura A case of polymyositis associated with Kawasaki disease Brain Dev 7 1985 513 515
299. D.B. Sullivan J.T. Cassidy R.E. Petty Dermatomyositis in the pediatric patient Arthritis Rheum 20 1977 327 331
300. G.L. Sussman W. Pruzanski The role of intravenous infusions of gamma globulin in the therapy of polymyositis and dermatomyositis J Rheumatol 21 1994 990 992
301. M.O. Swartz R.M. Silver d -Penicillamine induced polymyositis in juvenile chronic arthritis: Report of a case J Rheumatol 11 1984 251 252
302. J. Taborn G.G. Bole G.R. Thompson Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis Ann Intern Med 89 1978 648 649
303. A. Taieb C. Guichard R. Salamon Prognosis in juvenile dermatopolymyositis: A cooperative retrospective study of 70 cases Pediatr Dermatol 2 1985 275 281
304. V. Takayasu E. Hirose-Pastor R. Fuller [Minipulses of cyclophosphamide in the treatment of dermatopolymyositis with lung involvement] Rev Hosp Clin Fac Med São Paulo 47 1992 240 244
305. I.N. Targoff Immune manifestations of inflammatory muscle disease Rheum Dis Clin North Am 20 1994 857 880
306. M.M. Tellus R.R. Buchanan Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporine Br J Rheumatol 34 1995 1187 1188
307. C.E. Thompson Polymyositis in children Clin Pediatr 7 1968 24 28
308. H.A. Tiddens J.J. van der Net de Graeff-Meeder E.R. Juvenile-onset mixed connective tissue disease: Longitudinal follow-up J Pediatr 122 1993 191 197
309. F.M.S. Tome M. Fardeau P. Lebon Inclusion body myositis Acta Neuropathol 7 suppl 1981 287 291
310. M.K. Tuxen A. Aru Myositis focalis Ugeskr Laeger 154 1992 3600 3602
311. Y. Ueno K. Kondo N. Kidokoro Hepatitis C infection and polymyositis Lancet 346 1995 319 320
312. Van Rossum M.A. I. Hiemstra A.M. Prieur Juvenile dermato/polymyositis: A retrospective analysis of 33 cases with special focus on initial CPK levels Clin Exp Rheumatol 12 1994 339 342
313. V. Vedanarayanan S.H. Subramony L.I. Ray Treatment of childhood dermatomyositis with high dose intravenous immunoglobulin Pediatr Neurol 13 1995 336 339
314. L. Villalba E.M. Adams Update on therapy for refractory dermatomyositis and polymyositis Curr Opin Rheumatol 8 1996 544 551
315. M.L. Villalba J.E. Hicks B. Thornton A combination of oral methotrexate and azathioprine is more effective than high dose intravenous methotrexate with leuocovorin rescue in treatment-resistant myositis Arthritis Rheum 38 suppl 1995 307
316. S.A. Vogelgesang J. Gutierrez G.L. Klipple Polyneuropathy in juvenile dermatomyositis J Rheumatol 22 1995 1369 1372
317. C.A. Wallace D.D. Sherry A practical approach to avoidance of methotrexate toxicity J Rheumatol 22 1995 1009 1012
318. J. Walton The inflammatory myopathies J R Soc Med 76 1983 998 1010
319. W.J. Wang W.L. Lo C.K. Wong Calcinosis cutis in juvenile dermatomyositis: Remarkable responses to aluminum hydroxide therapy Arch Dermatol 124 1988 1721 1722
320. R.J.P. Wedgwood C.D. Cook J. Cohen Dermatomyositis: Report of 26 cases in children with a discussion of endocrine therapy in 13 Pediatrics 12 1953 447 466
321. D. Weidensaul T. Imam M.M. Holyst Polymyositis, pulmonary fibrosis, and hepatitis C Arthritis Rheum 38 1995 437 439
322. J.N. Whitaker Inflammatory myopathy: A review of etiologic and pathogenetic factors Muscle Nerve 5 1982 573 592
323. T.Y. Woo J.P. Callen J.J. Voorhees Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine J Am Acad Dermatol 10 1984 592 600
324. S. Yokota Mixed connective tissue disease in childhood Acta Paediatrica Japonica 35 1993 472 479
325. N. Yordam N. Kandemir H. Topaloglu Myositis associated with growth hormone therapy J Pediatr 125 1994 671
326. M. Yoshioka H. Tuda Y. Yoshida [Lymphoplasmapheresis in the management of refractory polymyositis in childhood] Rinsho Shinkeigaku 24 1984 214 217
327. R.S.K. Young B.L. Hodes R.P. Cruse Orbital pseudotumor and Crohn disease J Pediatr 99 1981 250 251
328. D. Zantos Y. Zhang D. Felson The overall and temporal association of cancer with polymyositis and dermatomyositis J Rheumatol 21 1994 1855 1859
329. M.E. Zieglschmid-Adams A.G. Pandya S.B. Cohen Treatment of dermatomyositis with methotrexate J Am Acad Dermatol 32 1995 754 757
330. U. Zifko W. Grisold [Dermatomyositis: successful therapy with high dosage intravenous 7S immunoglobulins] Wien Klin Wochenschr 107 1995 522 524